Hepatitis B Vaccine (Recombinant) Market Report

Global and Region Hepatitis B Vaccine (Recombinant) Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：180
  • REPORT CODE：GMM971157
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Hepatitis B Vaccine (Recombinant) market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Hepatitis B Vaccine (Recombinant)market, defines the market attractiveness level of Hepatitis B Vaccine (Recombinant) market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Hepatitis B Vaccine (Recombinant) industry, describes the types of Hepatitis B Vaccine (Recombinant) market, the applications of major players and the market size, and deeply analyzes the current situation of the global Hepatitis B Vaccine (Recombinant) market and the development prospects and opportunities of Hepatitis B Vaccine (Recombinant) industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Hepatitis B Vaccine (Recombinant) market in Chapter 13.

    By Player:

    • KM Biologics

    • Dynavax Technologies

    • Sanofi Pasteur

    • GSK

    • Merck

    • Shenzhen Kangtai Biological Products

    • Serum Institute

    • LG Life Sciences

    By Type:

    • 10mcg/05ml

    • 10mcg/ml

    By End-User:

    • Newborn

    • Adult

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Hepatitis B Vaccine (Recombinant) Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Hepatitis B Vaccine (Recombinant) Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Hepatitis B Vaccine (Recombinant) Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Hepatitis B Vaccine (Recombinant) Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Hepatitis B Vaccine (Recombinant) Market Analysis and Outlook to 2022

    • 7.1 Global Hepatitis B Vaccine (Recombinant) Consumption (2017-2022)

    • 7.2 United States Hepatitis B Vaccine (Recombinant) Consumption (2017-2022)

    • 7.3 Europe Hepatitis B Vaccine (Recombinant) Consumption (2017-2022)

    • 7.4 China Hepatitis B Vaccine (Recombinant) Consumption (2017-2022)

    • 7.5 Japan Hepatitis B Vaccine (Recombinant) Consumption (2017-2022)

    • 7.6 India Hepatitis B Vaccine (Recombinant) Consumption (2017-2022)

    • 7.7 South Korea Hepatitis B Vaccine (Recombinant) Consumption (2017-2022)

    8 Region and Country-wise Hepatitis B Vaccine (Recombinant) Market Analysis and Outlook to 2028

    • 8.1 Global Hepatitis B Vaccine (Recombinant) Consumption Forecast (2022-2028)

    • 8.2 United States Hepatitis B Vaccine (Recombinant) Consumption Forecast (2022-2028)

    • 8.3 Europe Hepatitis B Vaccine (Recombinant) Consumption Forecast (2022-2028)

    • 8.4 China Hepatitis B Vaccine (Recombinant) Consumption Forecast (2022-2028)

    • 8.5 Japan Hepatitis B Vaccine (Recombinant) Consumption Forecast (2022-2028)

    • 8.6 India Hepatitis B Vaccine (Recombinant) Consumption Forecast (2022-2028)

    • 8.7 South Korea Hepatitis B Vaccine (Recombinant) Consumption Forecast (2022-2028)

    9 Global Hepatitis B Vaccine (Recombinant) Market Outlook by Types and Applications to 2022

    • 9.1 Global Hepatitis B Vaccine (Recombinant) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global 10mcg/05ml Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global 10mcg/ml Consumption and Growth Rate (2017-2022)

    • 9.2 Global Hepatitis B Vaccine (Recombinant) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Newborn Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Adult Consumption and Growth Rate (2017-2022)

    10 Global Hepatitis B Vaccine (Recombinant) Market Outlook by Types and Applications to 2028

    • 10.1 Global Hepatitis B Vaccine (Recombinant) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global 10mcg/05ml Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global 10mcg/ml Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Hepatitis B Vaccine (Recombinant) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Newborn Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Adult Consumption Forecast and Growth Rate (2022-2028)

    11 Global Hepatitis B Vaccine (Recombinant) Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Hepatitis B Vaccine (Recombinant) Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Hepatitis B Vaccine (Recombinant) Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Hepatitis B Vaccine (Recombinant) Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Hepatitis B Vaccine (Recombinant) Market Competitive Analysis

    • 14.1 KM Biologics

      • 14.1.1 KM Biologics Company Details

      • 14.1.2 KM Biologics Hepatitis B Vaccine (Recombinant) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 KM Biologics Hepatitis B Vaccine (Recombinant) Product and Service

    • 14.2 Dynavax Technologies

      • 14.2.1 Dynavax Technologies Company Details

      • 14.2.2 Dynavax Technologies Hepatitis B Vaccine (Recombinant) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Dynavax Technologies Hepatitis B Vaccine (Recombinant) Product and Service

    • 14.3 Sanofi Pasteur

      • 14.3.1 Sanofi Pasteur Company Details

      • 14.3.2 Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Product and Service

    • 14.4 GSK

      • 14.4.1 GSK Company Details

      • 14.4.2 GSK Hepatitis B Vaccine (Recombinant) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 GSK Hepatitis B Vaccine (Recombinant) Product and Service

    • 14.5 Merck

      • 14.5.1 Merck Company Details

      • 14.5.2 Merck Hepatitis B Vaccine (Recombinant) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Merck Hepatitis B Vaccine (Recombinant) Product and Service

    • 14.6 Shenzhen Kangtai Biological Products

      • 14.6.1 Shenzhen Kangtai Biological Products Company Details

      • 14.6.2 Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Product and Service

    • 14.7 Serum Institute

      • 14.7.1 Serum Institute Company Details

      • 14.7.2 Serum Institute Hepatitis B Vaccine (Recombinant) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Serum Institute Hepatitis B Vaccine (Recombinant) Product and Service

    • 14.8 LG Life Sciences

      • 14.8.1 LG Life Sciences Company Details

      • 14.8.2 LG Life Sciences Hepatitis B Vaccine (Recombinant) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 LG Life Sciences Hepatitis B Vaccine (Recombinant) Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Hepatitis B Vaccine (Recombinant)

    • Figure Hepatitis B Vaccine (Recombinant) Picture

    • Table Global Hepatitis B Vaccine (Recombinant) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Hepatitis B Vaccine (Recombinant) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Hepatitis B Vaccine (Recombinant) Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Hepatitis B Vaccine (Recombinant) Consumption by Country (2017-2022)

    • Figure United States Hepatitis B Vaccine (Recombinant) Consumption and Growth Rate (2017-2022)

    • Table Europe Hepatitis B Vaccine (Recombinant) Consumption and Growth Rate (2017-2022)

    • Figure China Hepatitis B Vaccine (Recombinant) Consumption and Growth Rate (2017-2022)

    • Figure Japan Hepatitis B Vaccine (Recombinant) Consumption and Growth Rate (2017-2022)

    • Figure India Hepatitis B Vaccine (Recombinant) Consumption and Growth Rate (2017-2022)

    • Figure South Korea Hepatitis B Vaccine (Recombinant) Consumption and Growth Rate (2017-2022)

    • Figure Global Hepatitis B Vaccine (Recombinant) Consumption Forecast by Country (2022-2028)

    • Figure United States Hepatitis B Vaccine (Recombinant) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Hepatitis B Vaccine (Recombinant) Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Hepatitis B Vaccine (Recombinant) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Hepatitis B Vaccine (Recombinant) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Hepatitis B Vaccine (Recombinant) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Hepatitis B Vaccine (Recombinant) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global 10mcg/05ml Consumption and Growth Rate (2017-2022)

    • Figure Global 10mcg/ml Consumption and Growth Rate (2017-2022)

    • Figure Global Newborn Consumption and Growth Rate (2017-2022)

    • Figure Global Adult Consumption and Growth Rate (2017-2022)

    • Figure Global 10mcg/05ml Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global 10mcg/ml Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Newborn Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Adult Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Hepatitis B Vaccine (Recombinant) Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Hepatitis B Vaccine (Recombinant) Export by Region (Top 5 Countries) (2017-2028)

    • Table KM Biologics (Foundation Year, Company Profile and etc.)

    • Table KM Biologics Hepatitis B Vaccine (Recombinant) Sales, Price, Value and Gross Profit (2017-2022)

    • Table KM Biologics Hepatitis B Vaccine (Recombinant) Product and Service

    • Table Dynavax Technologies (Foundation Year, Company Profile and etc.)

    • Table Dynavax Technologies Hepatitis B Vaccine (Recombinant) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dynavax Technologies Hepatitis B Vaccine (Recombinant) Product and Service

    • Table Sanofi Pasteur (Foundation Year, Company Profile and etc.)

    • Table Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Product and Service

    • Table GSK (Foundation Year, Company Profile and etc.)

    • Table GSK Hepatitis B Vaccine (Recombinant) Sales, Price, Value and Gross Profit (2017-2022)

    • Table GSK Hepatitis B Vaccine (Recombinant) Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Hepatitis B Vaccine (Recombinant) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Hepatitis B Vaccine (Recombinant) Product and Service

    • Table Shenzhen Kangtai Biological Products (Foundation Year, Company Profile and etc.)

    • Table Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Product and Service

    • Table Serum Institute (Foundation Year, Company Profile and etc.)

    • Table Serum Institute Hepatitis B Vaccine (Recombinant) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Serum Institute Hepatitis B Vaccine (Recombinant) Product and Service

    • Table LG Life Sciences (Foundation Year, Company Profile and etc.)

    • Table LG Life Sciences Hepatitis B Vaccine (Recombinant) Sales, Price, Value and Gross Profit (2017-2022)

    • Table LG Life Sciences Hepatitis B Vaccine (Recombinant) Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US